# Sequent Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sequent-medical

- Industry: Medical Devices & Equipment
- Headquarters: Aliso Viejo, US
- Website: www.sequentmedical.com
- Total disclosed funding: $62M
- Latest round: Series D (Nov 14, 2014)
- Investors on record: 4

## About

Sequent Medical, Inc. specializes in innovative medical device solutions aimed at improving patient outcomes in the neurovascular sector, focusing on advanced technologies for the treatment of vascular diseases.Founded in 2007 and headquartered in Aliso Viejo, California, Sequent Medical, Inc. is dedicated to developing medical technologies for neurovascular applications. In June 2016, the company was acquired by Terumo Corporation for USD 280 mn, marking a significant milestone in its growth trajectory. The firm has successfully completed a total of 7 deals since its inception, demonstrating its active engagement in the medical device industry.Sequent Medical, Inc. offers a range of innovative medical devices specifically designed for neurovascular treatment. The company's core products focus on providing advanced solutions for managing vascular diseases, which include technologies that enhance the effectiveness of treatments while minimizing patient risks. These products are utilized by healthcare professionals in various medical settings, including hospitals and specialty clinics, ensuring better care for patients suffering from neurovascular conditions.The revenue model of Sequent Medical, Inc. is primarily based on the sales of its medical devices through direct agreements with healthcare providers. By establishing strong partnerships with hospitals and clinics, the company generates a dependable income stream from its innovative product offerings, which are priced to reflect the therapeutic benefits and improved patient outcomes they deliver.Sequent Medical, Inc. is focused on expanding its product line to include new technologies aimed at enhancing treatment options for neurovascular diseases. With the recent acquisition by Terumo Corporation, there are plans to leverage this partnership to penetrate additional markets in Asia and Europe by 2025. The funding received from the acquisition will support the development of new products and facilitate entry into these targeted geographic regions, enabling Sequent Medical to build upon its existing portfolio and meet the growing demand for innovative medical solutions.

## Funding rounds

- Series D, Nov 14, 2014, $0.1M — Delphi Ventures, Domain Associates, US Venture Partners, Versant Ventures
- Series D, Mar 27, 2014, $20M — Delphi Ventures, Domain Associates, US Venture Partners, Versant Ventures
- Series C, Mar 6, 2012, $26M — Delphi Ventures, Domain Associates, US Venture Partners, Versant Ventures
- Series B, May 12, 2010, $16M — Domain Associates, US Venture Partners, Versant Ventures

## Investors

- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series B, Series C, Series D
- US Venture Partners (https://capitalatlas.ai/funds/us-venture-partners) — Series B, Series C, Series D
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series B, Series C, Series D
- Delphi Ventures (https://capitalatlas.ai/funds/delphi-ventures) — Series C, Series D